These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6661336)

  • 1. [Immunological monitoring of brain tumors--prognosis and cellular immunity of patients with brain tumors].
    Yokoyama H; Hara M; Ogashiwa M; Takeuchi K
    No To Shinkei; 1983 Nov; 35(11):1103-8. PubMed ID: 6661336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological examination in patients with brain tumor and the usefulness of PHA skin test (author's transl)].
    Imagawa K; Tochio H; Toda I; Hayashi M; Asai A; Nomura T; Miyaji H
    No To Shinkei; 1978 Nov; 30(11):1171-6. PubMed ID: 728272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
    Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
    No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of tumor specific immunological response in the patients with malignant brain tumors by the mixed lymphocyte-tumor cell reaction].
    Yoshida S; Takai N; Ono K; Saito T; Tanaka R
    No To Shinkei; 1988 Nov; 40(11):1067-73. PubMed ID: 2975495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytohemagglutinin (PHA) skin test. Characterization of immunological properties and clinical application.
    Nishido T
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):43-55. PubMed ID: 371848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
    Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
    Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of cellular immunity to prognosis in acute leukemia.
    Toki H; Takahashi Y; Nakanishi N; Naito T; Chen P; Takahashi I; Kitajima K
    Acta Med Okayama; 1977 Feb; 31(1):51-8. PubMed ID: 140590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PPD, PHA and Su-PS skin tests in genitourinary malignancies].
    Amano T; Koshida K; Nakajima K; Naito K; Hisazumi H
    Hinyokika Kiyo; 1985 Dec; 31(12):2107-11. PubMed ID: 3914213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation index as a predictor of prognosis in malignant gliomas of childhood.
    Pollack IF; Campbell JW; Hamilton RL; Martinez AJ; Bozik ME
    Cancer; 1997 Feb; 79(4):849-56. PubMed ID: 9024724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of cyclin D1 in brain gliomas and its significance].
    Tan PG; Xing Z; Li ZQ
    Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular immunity of the patients with malignant glioma -- with special reference to the depressed cell-mediated immunity of the cerebrospinal (author's transl)].
    Uemura S; Wada S; Kodama T; Matsukado Y
    No Shinkei Geka; 1977 Aug; 5(9):931-9. PubMed ID: 303336
    [No Abstract]   [Full Text] [Related]  

  • 13. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
    Blomgren H; Blom U; Ullén H
    Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of the natural killer cells in the peripheral blood of patients with brain tumors].
    Lisianyĭ NI; Markova OV; Zhmareva EN
    Eksp Onkol; 1988; 10(3):57-9. PubMed ID: 3409835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of the phytohemagglutinin intradermal reaction in patients in an intensive care unit].
    Krajevitch A; Nal JN
    Ann Anesthesiol Fr; 1981; 22(3):245-9. PubMed ID: 6117229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recording of cell-mediated immunity in patients with gliomatous brain tumors].
    Lambrecht R; Willenberg E; Plate M
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(3):167-71. PubMed ID: 3751205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of cellular immunity in patients with rheumatoid arthritis by phytohaemagglutinin skin test.
    Kaćaki J; Budimir M; Berović Z
    Rheumatology; 1975; 6():72-9. PubMed ID: 1202609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of immunological skin reactions in patients with active pulmonary tuberculosis. 1. A comparative study on the relationship among 4 reactions (PPD, DNCB, PHA and Candida skin reactions)].
    Ishibashi J
    Kekkaku; 1982 Nov; 57(11):585-9. PubMed ID: 7162014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.